Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum AVEO Pharmaceuticals Inc. AVEO

AVEO Pharmaceuticals Inc is a commercial-stage, oncology-focused biopharmaceutical company engaged in offering medicines that provide a better life for patients with cancer. The company markets FOTIVDA (tivozanib) in the United States.

Bullboard (NDAQ:AVEO)

View:
Comment by ARNULFon Jul 09, 2018 5:11pm

RE:RE:RE:RE:RE:Wow

I was so lucky. Watch this for a little while and seen its was starting to move on Friday. So today from my phone while driving I scooped up 5000 shares at 2.53. Never done that before. I was going to ...more  
Comment by mevanion Jul 09, 2018 4:12pm

RE:RE:RE:RE:Wow

Seems it’s shaping that way.  What a great day today.  Good volume last  15 minutes of trading.  Tomorrow should be interesting.  
Comment by ARNULFon Jul 04, 2018 9:50am

RE:RE:RE:Wow

Well I guess something to a buyout with AVEO. Thanks to the other board I’m monitoring https://www.businesswire.com/news/home/20180201006348/en/AVEO-Announces-Appointment-John-H.-Johnson-Board
Comment by ARNULFon Jul 03, 2018 6:38pm

RE:RE:Wow

I’m reading other boards and there’s a complete pump job going on with AVEO. Today Novartis and AVEO terminate agreement. One would think that AVEO would dive but price is stable. Also delayed trials ...more  
Comment by mevanion Jun 27, 2018 2:50pm

RE:Wow

I agree. Accumulating on the dips.
Post by billybob22on Jun 27, 2017 11:06am

Wow

What a great run with more to come.....
Post by billybob22on Jun 23, 2017 2:20pm

Fanastic N.R today

AVEO Oncology Announces Positive CHMP Opinion for Tivozanib as a Treatment of Advanced Renal Cell Carcinoma Read more at https://www.stockhouse.com/news/press-releases/2017/06/23/aveo-oncology ...more  
Post by peterfridayon Mar 15, 2016 5:16am

Oncology specialist up14%, new financing campaing seem to go

Possibly a real turnaround for Aveo pharmacetical with a new Renal trial study, but always risky business the medical research so slow to progress...
Post by peterfridayon Feb 22, 2016 4:38am

Oncology specialist up 2%,is it a real turnaround financing

Seem to be a serious research in cancer tharapy, but so costly and risky.Any new financing campaing on the air... 
Post by osirus1on Dec 22, 2015 12:11am

$500 million deal

SEC filing https://www.sec.gov/Archives/edgar/data/1325879/000119312515408437/0001193125-15-408437-index.htm
Post by peterfridayon Dec 03, 2015 5:42am

Aveo possibly to break record revenu with new patents

New patents on the market against cancer epidemy, possibly one of the best to follow among so many competitors. Antidepressive new medecine like cacao by-products would have been more popular there ...more  
Post by Moocheeon Aug 17, 2015 10:17am

Check out ONCY / ONC.TO

Similar company, it is currently in trials -, once it gets approved / a bigger player might swoop it up. Patents are abundant as well.
Post by 2PackHabbiton Aug 17, 2015 9:24am

Double

This 1 is a good 1 to already own.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities